Study suggests gene mutation could improve effectiveness of drug used to treat acute myeloid leukemia

Author：  

Publisher： Future Medicine

ISSN： 1462-2416

Source： Pharmacogenomics, Vol.9, Iss.8, 2008-08, pp. : 993-996

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Drug Resistance in Childhood Acute Myeloid Leukemia

By  

Current Pharmaceutical Biotechnology, Vol. 8, Iss. 2, 2007-04 ,pp. : 59-75

Bentham Science Publishers

Access to resources Recommend Favorite

Elacytarabine – lipid vector technology overcoming drug resistance in acute myeloid leukemia

By Burke Aine Carol   Giles Frank James  

Expert Opinion on Investigational Drugs, Vol. 20, Iss. 12, 2011-12 ,pp. : 1707-1715

Informa Healthcare

Access to resources Recommend Favorite

Acute Myeloid Leukemia

By  

Journal of the National Comprehensive Cancer Network (JNCCN), Vol. 6, Iss. 10, 2008-11 ,pp. : 962-962

Cambridge Scholars Publishing in association with GSE Research

Access to resources Recommend Favorite

Pharmacogenomics in acute myeloid leukemia

By Roumier Christophe   Cheok Meyling H  

Pharmacogenomics, Vol. 10, Iss. 11, 2009-11 ,pp. : 1839-1851

Future Medicine

Access to resources Recommend Favorite

Immunotherapy in acute myeloid leukemia

By  

Cancer, Vol. 121, Iss. 16, 2015-08 ,pp. : 2689-2704

Blackwell Publishing

Access to resources Recommend Favorite